tiprankstipranks
Trending News
More News >

Mayne Pharma to be Acquired by Cosette Pharmaceuticals

Story Highlights
  • Mayne Pharma is being acquired by Cosette Pharmaceuticals through a scheme of arrangement.
  • Mayne Pharma shared non-material information with Cosette, not requiring market disclosure.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Mayne Pharma to be Acquired by Cosette Pharmaceuticals

Confident Investing Starts Here:

Mayne Pharma Group ( (AU:MYX) ) has shared an update.

Mayne Pharma Group Limited has entered into a Scheme Implementation Deed with Cosette Pharmaceuticals Inc, under which Cosette will acquire 100% of Mayne Pharma’s shares through a scheme of arrangement. The company has been sharing information with Cosette as part of this agreement, including a non-material Untitled Letter related to a speaker presentation for NEXTSTELLIS®. Mayne Pharma confirmed that the letter does not impact its ability to sell and distribute NEXTSTELLIS® in the United States and does not consider it materially price sensitive, thus not requiring market disclosure.

The most recent analyst rating on (AU:MYX) stock is a Buy with a A$7.09 price target. To see the full list of analyst forecasts on Mayne Pharma Group stock, see the AU:MYX Stock Forecast page.

More about Mayne Pharma Group

Mayne Pharma Group Limited is a pharmaceutical company that focuses on developing and manufacturing branded and generic pharmaceutical products. The company is involved in the distribution of its products across various markets, with a particular emphasis on the United States.

Average Trading Volume: 811,987

Technical Sentiment Signal: Buy

Current Market Cap: A$526.5M

Find detailed analytics on MYX stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1